Concepedia

Author

Katsuhiko Masudo

Yokohama City UniversityORCID

Also Known As

K Masudo, K. Masudo, KATSUHIKO MASUDO, Katsuhiko MASUDO, Katsuhiko Masudo, Masudo, Katsuhiko

69

Publications

1.2K

Citations

17

H-Index

26

Concepts

All Affiliations

Yokohama City UniversityKanagawa Prefectural Hospital OrganizationKanagawa Cancer CenterYokohama City University Medical CenterYokohama City University Hospital
KM

About

Katsuhiko Masudo is an author at Yokohama City University specializing in medicine, pathology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

265

2

Pathology

6

6

241

3

Surgical Oncology

4

4

114

4

Health Sciences

3

3

69

5

Pharmacology

1

1

45

Katsuhiko Masudo

×

28

Publications

1.1K

Citations

17

H-Index

YearCitations

Thyroid Lobectomy for Papillary Thyroid Cancer: Long‐term Follow‐up Study of 1,088 Cases

Kenichi Matsuzu, Kiminori Sugino, Katsuhiko Masudo,

World Journal of Surgery

2013

329

Aberrant Nuclear Localization and Gene Mutation of β-catenin in Low-Grade Adenocarcinoma of Fetal Lung Type: Up-Regulation of the Wnt Signaling Pathway May Be a Common Denominator for the Development of Tumors that Form Morules

Yukio Nakatani, Katsuhiko Masudo, Yohei Miyagi,

Modern Pathology

2002

122

Clinical outcomes in older or younger patients with papillary thyroid carcinoma: Impact of lymphadenopathy and patient age

Nobuyuki Wada, Katsuhiko Masudo, Hirotaka Nakayama,

European Journal of Surgical Oncology

2007

71

Microscopic regional lymph node status in papillary thyroid carcinoma with and without lymphadenopathy and its relation to outcomes

Nobuyuki Wada, Nobuyasu Suganuma, Hirotaka Nakayama,

Langenbeck s Archives of Surgery

2007

63

Clinical Significance of INHBA Gene Expression in Patients with Gastric Cancer who Receive Curative Resection Followed by Adjuvant S-1 Chemotherapy

Yusuke Katayama, Takashi Oshima, Kentaro Sakamaki,

In Vivo

2017

50

Lenvatinib as a novel treatment for anaplastic thyroid cancer: A retrospective study

Hiroyuki Iwasaki, Haruhiko Yamazaki, Hirotaka Takasaki,

Oncology Letters

2018

45

Evaluation of the 8th Edition TNM Classification for Anaplastic Thyroid Carcinoma

Naoyoshi Onoda, Iwao Sugitani, Ken‐ichi Ito,

Cancers

2020

39

Efficacy and tolerability of initial low-dose lenvatinib to treat differentiated thyroid cancer

Haruhiko Yamazaki, Hiroyuki Iwasaki, Hirotaka Takasaki,

Medicine

2019

30

Lenvatinib vs. palliative therapy for stage IVC anaplastic thyroid cancer

Hiroyuki Iwasaki, Soji Toda, Nobuyasu Suganuma,

Molecular and Clinical Oncology

2019

30

Potential Risk Factors for Nivolumab-induced Thyroid Dysfunction

Haruhiko Yamazaki, Hiroyuki Iwasaki, Toshinari Yamashita,

In Vivo

2017

29

Page 1